The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 169.20
Bid: 167.80
Ask: 169.00
Change: 6.60 (4.06%)
Spread: 1.20 (0.715%)
Open: 169.20
High: 169.20
Low: 161.60
Prev. Close: 162.60
FORT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Covid-19

24 Mar 2020 14:50

RNS Number : 4163H
Forterra plc
24 March 2020
 

FORTERRA plc

 

24 March 2020

 

Update on Covid-19

Forterra plc, a leading UK producer of manufactured masonry products, provides an update on Covid-19 and the measures it is taking to mitigate the impact on its business.

Colleagues and customers

The health, safety and wellbeing of our employees remains our primary concern and we have already taken prompt action to allow our colleagues to work from home wherever possible and eliminated all unnecessary travel.

In light of the new Government guidance, and in order to protect our workforce, the Board has decided to suspend all business operations as soon as possible until further notice. In some cases shutting down our facilities in a controlled and safe manner will take several days, and we will take all necessary measures to ensure our factories can efficiently resume production at the appropriate time.

The Board welcomes the Government's announcement that funding will be available to ensure employees can still be paid a proportion of their salary during a period of furlough and anticipates making use of this facility.

Balance sheet and liquidity

The Group enters this uncertain time with a strong balance sheet. We ended 2019 with net debt (pre IFRS 16) of £43.2m. This represents a multiple of 0.6 times EBITDA on a pre IFRS 16 basis.

The Group has access to a £150m revolving credit facility extending to July 2022. In recent days the Group has taken the precautionary action of drawing this facility. At the present time the Group has cash reserves of c£70m and access to an undrawn overdraft facility of £10m. In addition, the Group's credit agreement includes a £50m uncommitted accordion facility on the same terms as the main facility.

We are in regular discussion with the Company's lenders, all of whom remain supportive, to understand what future funding options may be available to the Company in light of recent Government announcements.

Actions

Given the unprecedented level of uncertainty we now face with significant economic disruption ahead, the Board has taken several immediate actions to protect the Group's liquidity position including:

Cost reduction and cash preservation: Prior to the decision to temporarily cease operations we had already taken actions to halt all non-essential discretionary expenditure. Existing commitments for capital expenditure will be honoured although we expect our suppliers and contractors to also face significant disruption in the coming months. No new commitments will be entered into. The Board remains committed to the completion of the new Desford brick factory although the phasing of expenditure will be flexed according to circumstance.

2019 final dividend suspended: Our recent full year results announcement stated that the Board would propose the payment of a final dividend of 7.5 pence per share. If approved by shareholders at the AGM this would lead to a cash outflow of c£15m in July. Whilst the Board recognises the importance of the dividend to shareholders, in the current circumstances the Board feels that it is no longer appropriate to make this payment and this resolution will be removed from the AGM notice sent to shareholders in the coming weeks.

At this stage the Board is unable to quantify what impact Covid-19 and the actions we are taking will have on the 2020 results and as such is currently unable to provide meaningful guidance on future earnings.

Upcoming AGM

The Company's AGM is currently scheduled for 14 May 2020. This is being kept under review and a further announcement will be made in due course.

Enquiries:

Forterra plc:

+44 (0) 1604 707 600

Stephen Harrison (CEO) / Ben Guyatt (CFO)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain/Nick Hasell

 

Further information relating to the Company and its group can be found at www.forterraplc.co.uk.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDUSSSRRWUOUAR
Date   Source Headline
15th Apr 20241:46 pmRNSAnnual Report & Accounts 2023 & Notice of AGM 2024
12th Apr 202412:09 pmRNSDirector/PDMR Shareholding
9th Apr 20244:22 pmRNSDirector/PDMR Shareholding
9th Apr 20244:19 pmRNSDirector/PDMR Shareholding
3rd Apr 20242:19 pmRNSDirector/PDMR Shareholding
27th Mar 20244:44 pmRNSDirector/PDMR Shareholding
25th Jan 202412:27 pmRNSDirector Declaration
24th Jan 20247:19 amRNSProgressive publish new research
24th Jan 20247:00 amRNS2023 Trading Update
23rd Jan 20247:00 amRNSHolding(s) in Company
8th Dec 20237:00 amRNSDirector Declaration
9th Nov 20237:00 amRNSAppointment of Joint Corporate Broker
20th Oct 20236:05 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSQ3 Trading Update
5th Oct 20235:04 pmRNSGrant of Options under 2023 SAYE Scheme
11th Sep 20237:00 amRNSHolding(s) in Company
1st Sep 20235:46 pmRNSHolding(s) in Company
23rd Aug 20233:59 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSSix months ended 30 June 2023
11th Jul 20237:00 amRNSPost close half year trading update
5th Jul 202312:39 pmRNSEmployee Benefit Trust Share Purchase
30th Jun 20231:51 pmRNSHolding(s) in Company
6th Jun 202312:57 pmRNSEmployee Benefit Trust Share Purchase
23rd May 20232:22 pmRNSAnnual General Meeting 2023 Results
18th May 202312:12 pmRNSProgressive publish new research
16th May 20237:00 amRNSPre-AGM trading update
5th May 20234:39 pmRNSDirector/PDMR Shareholding
4th May 20239:00 amRNSEmployee Benefit Trust Share Purchase
25th Apr 20237:00 amRNSNotification of Board Changes
11th Apr 20234:15 pmRNSPCA Shareholdings
4th Apr 20231:12 pmRNSEmployee Benefit Trust Share Purchase
3rd Apr 20232:03 pmRNSGrant under Performance Share Plan
29th Mar 202310:21 amRNSAnnual Report & Accounts 2022 & Notice of AGM 2023
16th Mar 20235:28 pmRNSGrant under Deferred Annual Bonus Plan
10th Mar 20239:18 amRNSProgressive publishes new research
9th Mar 20237:02 amRNSAppointment of Independent Non-Executive Director
9th Mar 20237:00 amRNSFull Year Results
3rd Mar 20232:18 pmRNSEmployee Benefit Trust Share Purchase
3rd Feb 202310:13 amRNSEmployee Benefit Trust Share Purchase
1st Feb 20238:18 amRNSDirector Declaration
25th Jan 20237:00 amRNSTrading Update
5th Jan 20233:12 pmRNSEmployee Benefit Trust Share Purchase
14th Dec 20225:10 pmRNSEmployee Benefit Trust Share Purchase
8th Dec 20227:00 amRNSHolding(s) in Company
2nd Dec 20224:10 pmRNSEmployee Benefit Trust Share Purchase
22nd Nov 20227:54 amRNSProgressive publishes new research
22nd Nov 20227:01 amRNSAppointment of Chief Executive Officer
22nd Nov 20227:00 amRNSTrading Update
4th Nov 20222:50 pmRNSEmployee Benefit Trust Share Purchase
2nd Nov 20228:45 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.